Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$906.77M
Total Bought
$97.89M
Total Sold
$0
Net Transaction
+$97.89M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
SPDR S&P 500 ETF TR(SPY)1,146,9791,202,804+55,825624,209690,12176.11%+65,912
VANGUARD INTL EQUITY INDEX F0507,600+507,600031,9793.53%+31,979
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440135,275141,94415.65%+6,669
FOGHORN THERAPEUTICS INC1,573,7611,573,76109,04914,6521.62%+5,603
ORIC PHARMACEUTICALS INC(ORIC)989,410989,41006,99510,1411.12%+3,146
ALECTOR INC1,307,8581,307,85805,9386,0950.67%+157
SURROZEN INC87,69687,69609601,0510.12%+90
SURROZEN INC170,833170,8330320.00%-1
PMV PHARMACEUTICALS INC2,627,6432,627,64304,2573,9150.43%-342
23ANDME HOLDING CO10,243,12210,243,12204,0073,5850.40%-422
RAPT THERAPEUTICS INC657,899657,89902,0071,3220.15%-684
TENAYA THERAPEUTICS INC1,015,7051,015,70503,1491,9600.22%-1,188
Page 1 of 1